A eukaryotic-like ubiquitination system in bacterial antiviral defence
Nature · 25.07.2024 · 631 (8022) · 843-849
DOI: 10.1038/s41586-024-07730-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 17.07.2024. Verfasst von Lydia R Chambers und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Bacterial Proteins, Bacteriophages, Escherichia, Ubiquitin-Activating Enzymes. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCCIH NIH HHS, NIH HHS.
Abstract (Originalsprache)
Ubiquitination pathways have crucial roles in protein homeostasis, signalling and innate immunity1-3. In these pathways, an enzymatic cascade of E1, E2 and E3 proteins conjugates ubiquitin or a ubiquitin-like protein (Ubl) to target-protein lysine residues4. Bacteria encode ancient relatives of E1 and Ubl proteins involved in sulfur metabolism5,6, but these proteins do not mediate Ubl-target conjugation, leaving open the question of whether bacteria can perform ubiquitination-like protein conjugation. Here we demonstrate that a bacterial operon associated with phage defence islands encodes a complete ubiquitination pathway. Two structures of a bacterial E1-E2-Ubl complex reveal striking architectural parallels with canonical eukaryotic ubiquitination machinery. The bacterial E1 possesses an amino-terminal inactive adenylation domain and a carboxy-terminal active adenylation domain with a mobile α-helical insertion containing the catalytic cysteine (CYS domain). One structure reveals a pre-reaction state with the bacterial Ubl C terminus positioned for adenylation, and a second structure mimics an E1-to-E2 transthioesterification state with the E1 CYS domain adjacent to the bound E2. We show that a deubiquitinase in the same pathway preprocesses the bacterial Ubl, exposing its C-terminal glycine for adenylation. Finally, we show that the bacterial E1 and E2 collaborate to conjugate Ubl to target-protein lysine residues. Together, these data reveal that bacteria possess bona fide ubiquitination systems with strong mechanistic and architectural parallels to canonical eukaryotic ubiquitination pathways, suggesting that these pathways arose first in bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, USA.
- Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
- Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
- Department of Biochemistry, University of Colorado Boulder, Boulder, CO, USA.
- School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
- Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA. kcorbett@ucsd.edu.
ORCID-Profile: Qiaozhen Ye, Jiaxi Cai, Huilin Zhou, Aaron T Whiteley, Kevin D Corbett
Förderung
- NIGMS NIH HHS
- NCCIH NIH HHS
- NIH HHS
Zitieren
APA
Chambers, L. R., Ye, Q., Cai, J., Gong, M., Ledvina, H. E., Zhou, H., Whiteley, A. T., Suhandynata, R. T., & Corbett, K. D. (2024). A eukaryotic-like ubiquitination system in bacterial antiviral defence. Nature, 631(8022), 843-849. https://doi.org/10.1038/s41586-024-07730-4
Vancouver
Chambers LR, Ye Q, Cai J, Gong M, Ledvina HE, Zhou H, et al. A eukaryotic-like ubiquitination system in bacterial antiviral defence. Nature. 2024;631(8022):843-849. doi:10.1038/s41586-024-07730-4
BibTeX
@article{Chambers2024,
author = {Chambers, Lydia R and Ye, Qiaozhen and Cai, Jiaxi and Gong, Minheng and Ledvina, Hannah E and Zhou, Huilin and Whiteley, Aaron T and Suhandynata, Raymond T and Corbett, Kevin D},
title = {A eukaryotic-like ubiquitination system in bacterial antiviral defence},
journal = {Nature},
year = {2024},
volume = {631},
number = {8022},
pages = {843--849},
doi = {10.1038/s41586-024-07730-4}
}
EUVIMED